Target intelligence / Profile preview

Corneal and conjunctival epithelium

Molecular classification
Other
01

Overview

The **corneal and conjunctival epithelium** refer to two distinct, continuous, nonkeratinized, stratified epithelial cell layers that cover the ocular surface of the eye. The **corneal epithelium** is centrally located, highly specialized for transparency, and consists of 5–7 layers of epithelial cells, enabling light entry while serving a critical barrier function. The **conjunctival epithelium** lines the white (sclera) part of the eye and the inside of the eyelids, consists of 3–5 layers, and contains goblet cells that contribute mucins to the tear film, supporting lubrication and immune protection of the ocular surface. These epithelia are maintained by unique populations of stem cells (limbal stem cells for the corneal epithelium and epithelial stem cells in the fornical conjunctiva for conjunctiva). Dysfunctions or diseases affecting these epithelia contribute to a range of ocular surface disorders, infections, inflammatory conditions, and neoplasms (tumors), but the tissue as a whole is not itself a molecular receptor or classic therapeutic target.

02

Mechanism of action

Physical protection or lubrication (artificial tears); Anti-inflammatory/modulation of immune response (corticosteroids, cyclosporine); Antimicrobial actions; Inhibition of cell proliferation (e.g., mitomycin C inhibits DNA synthesis in rapidly dividing epithelial neoplastic cells).

03

Biological functions

Physical barrier to infection and injuryTear film support (mucin secretion, especially in conjunctival epithelium)Immune defense (with mucosa-associated lymphoid tissue)Optical transparency (especially the corneal epithelium)Cell renewal (thanks to tissue-specific epithelial stem cells)
04

Disease associations

Infection (e.g., conjunctivitis, keratitis)Inflammation (e.g., dry eye disease, allergic conjunctivitis)Tumor formation (e.g., epithelial neoplasms of the conjunctiva)Scarring, surface disorders (e.g., limbal stem cell deficiency)Other ocular surface diseases (e.g., pterygium)
05

Safety considerations

Non-specific drug toxicity (e.g., epithelial toxicity with some topical drugs/chemotherapeutics)Potential for impaired wound healing or scarringRisk of compromising barrier function and increasing infection susceptibilitySystemic absorption of topical drugs is minimal but possible through ocular and nasal mucosa
06

Interacting drugs

Lubricating eye drops (artificial tears)

4 more in the full profile.

07

Biomarkers

Cytokeratin expression patterns (e.g., CK3/CK12 for corneal, CK19, CK4 for conjunctival)Goblet cell density (for conjunctival health/diagnosis of dry eye)Limbus-specific molecular markers (e.g., p63 for stem cells)

Beyond the preview

Go deeper on Corneal and conjunctival epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal and conjunctival epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call